multiomics
The ability to perform larger and more complex multiomic experiments raises questions and opportunities around integrating data and extracting scientific insights.
The company shared results from a larger case-control study in a recent preprint, and has already begun recruiting for a large prospective follow-up.
Cofactor Quickly Moving Immunotherapy Predictive Test to Market With Data From Intermountain Spinout
Premium
Culmination Bio's 4.5 million biospecimens and longitudinal omics and clinical data may help Cofactor rapidly advance the OncoPrism assay into multiple cancer types.
Freenome, Siemens Healthineers Partner to ID Blood-Based Breast Cancer Biomarkers
The companies aim to use multiomic and other types of data to identify blood-based biomarkers that can help in the early diagnosis of breast cancer.
Caris Life Sciences Raises $830M to Support Precision Medicine Platform, Liquid Biopsy Development
The funds will help support Caris' ongoing commercial efforts in comprehensive cancer genomics as it makes new forays into liquid biopsy for multi-cancer early detection.